The experimental mRNA shot, tested in macaques, generated a stronger immune response and dramatically reduced the number of ...

A new type of mpox, clade Ib, has been spreading rapidly within the Democratic Republic of Congo and leaking outside the ...

In late August the WHO declared a surging outbreak of mpox in Africa a public health emergency of international concern, the ...

Research from the drug company Moderna suggests its new mpox vaccine, based on mRNA technology, might be more effective than ...

Amid mounting concerns about the spread of mpox, an experimental vaccine from Moderna may be poised to offer additional ...

Rich nations have millions of mpox vaccine doses while Africa faces severe shortages amid a growing outbreak. Moderna ...

An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease ...

Moderna Inc (NASDAQ:MRNA) unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, ...

Investigational mpox mRNA vaccine, developed by Moderna, reduces disease severity in primates compared to available vaccines.

Current vaccines against mpox were designed to fight an older, rarer cousin of the virus, smallpox. Now, new research from ...

A recent study published in Cell shows that Moderna's experimental mRNA vaccine for mpox is more effective than existing ...

Current vaccines against mpox were designed to fight an older, rarer cousin of the virus, smallpox. Now, new research from the drug company Moderna suggests its new mpox vaccine, based on mRNA ...